You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,589,960


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,589,960
Title: Hydromorphone and hydrocodone compositions and methods for their synthesis
Abstract:A method for the preparation of a ketone from a narcotic alkaloid having an allyl alcohol moiety is disclosed. The method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the substantial absence of hydrogen gas. The method is useful for preparing hydromorphone and hydrocodone compositions having novel impurity profiles. Compositions comprising hydromorphone and hydrocodone are also disclosed.
Inventor(s): Harclerode; William H. (Asbury, NJ), Gault; Robert (Gross Pointe Woods, MI), Sandison; Mark D. (Dearborn, MI)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:10/256,996
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,589,960
Patent Claim Types:
see list of patent claims
Composition; Process; Use;
Patent landscape, scope, and claims:

United States Patent 6,589,960: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 6,589,960, titled "Hydromorphone and hydrocodone compositions and methods for their synthesis," is a significant patent in the field of pharmaceutical chemistry, particularly in the synthesis of narcotic alkaloids. This article will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Scope of the Patent

Overview

The patent describes methods and compositions related to the synthesis of hydromorphone and hydrocodone, which are important opioid analgesics. The invention focuses on improving the yield and purity of these compounds, which are derived from morphine and codeine[1][4].

Key Components

  • Narcotic Alkaloids: The patent involves the use of morphine, codeine, or their salts as the starting materials.
  • Synthesis Method: The method involves mixing the narcotic alkaloid with an acid in the presence of a catalyst, specifically in the substantial absence of hydrogen gas. This approach is designed to enhance the yield and reduce impurities[1][4].

Claims of the Patent

Main Claims

  • The patent claims a method for preparing a ketone from a narcotic alkaloid having an allyl alcohol moiety. This method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst without hydrogen gas[1][4].
  • The claims also cover the resulting compositions, particularly hydromorphone compositions that are substantially free of impurities.

Dependent Claims

  • The dependent claims further specify the types of acids and catalysts that can be used, such as platinum or palladium black, and the conditions under which the reaction is carried out[1][4].

Patent Landscape

Prior Art

The patent landscape in this area is rich with prior art that has laid the groundwork for the current invention. Previous patents, such as U.S. Pat. No. 2,544,291, U.S. Pat. No. 2,628,962, and U.S. Pat. No. 2,654,756, have described various methods for synthesizing dihydrocodone and other narcotic ketones. These methods often involved the use of supported palladium catalysts, aluminum alkoxides, and other reagents to achieve varying yields[1][4].

Innovations

The current patent offers several innovations over prior art:

  • Higher Yields: The method described achieves higher yields compared to some of the earlier methods. For example, the use of smaller amounts of catalyst can result in yields ranging from 70% to 95% of the theoretical yield[1].
  • Purity: The process ensures that the resulting hydromorphone compositions are substantially free of impurities, which is crucial for pharmaceutical applications[1][4].

Competitive Landscape

The patent landscape in the field of opioid synthesis is competitive, with multiple players contributing to the development of new methods and compositions. Companies and research institutions are continually seeking to improve the efficiency, yield, and purity of these compounds to meet the demands of the pharmaceutical industry.

Methodology and Process

Synthesis Process

The synthesis process involves several key steps:

  • Reaction Setup: The narcotic alkaloid (morphine or codeine) is mixed with an acid in the presence of a catalyst.
  • Reaction Conditions: The reaction is carried out in the substantial absence of hydrogen gas, which is a critical factor in achieving the desired yields and purity.
  • Purification: The reaction mixture is purified to obtain the final product, which is a ketone derivative of the narcotic alkaloid[1][4].

Catalysts and Reagents

The choice of catalysts and reagents is crucial in this process. Catalysts such as platinum or palladium black are commonly used, and the selection of acid can influence the yield and purity of the final product[1][4].

Impact on the Pharmaceutical Industry

Improved Efficiency

The methods described in this patent offer significant improvements in efficiency and yield, which can reduce production costs and increase the availability of these critical analgesics.

Enhanced Purity

The ability to produce hydromorphone and hydrocodone with reduced impurities is vital for ensuring the safety and efficacy of these drugs. This is particularly important in the pharmaceutical industry, where regulatory standards are stringent.

Regulatory and Legal Considerations

Patent Term and Protection

The patent provides a 20-year term of protection from the date of filing, subject to the payment of maintenance fees. This protection is limited to the United States, U.S. territories, and U.S. possessions[5].

Compliance with Patent Laws

The patent must comply with all the conditions and requirements of the law, including the disclosure of a new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof[5].

Conclusion

United States Patent 6,589,960 represents a significant advancement in the synthesis of hydromorphone and hydrocodone. The patent's claims and scope highlight the innovative methods and compositions that improve the yield and purity of these important opioid analgesics. Understanding the broader patent landscape and the competitive environment in this field is essential for researchers and industry professionals looking to contribute to or utilize these advancements.

Key Takeaways

  • Improved Synthesis Method: The patent describes a method for synthesizing hydromorphone and hydrocodone with higher yields and purity.
  • Critical Role of Catalysts: The use of specific catalysts and reaction conditions is crucial for achieving the desired outcomes.
  • Pharmaceutical Impact: The invention has significant implications for the pharmaceutical industry, enhancing efficiency and ensuring the safety and efficacy of opioid analgesics.
  • Regulatory Compliance: The patent must adhere to all relevant patent laws and regulations.

FAQs

What are the main components involved in the synthesis method described in the patent?

The main components include morphine or codeine as the starting materials, an acid, and a catalyst such as platinum or palladium black, all used in the substantial absence of hydrogen gas.

How does the patent improve upon prior art in the field?

The patent improves upon prior art by achieving higher yields (70% to 95%) and ensuring the resulting compositions are substantially free of impurities.

What is the significance of using specific catalysts in the synthesis process?

The use of specific catalysts such as platinum or palladium black is critical for achieving the desired yields and purity of the final product.

How does the patent impact the pharmaceutical industry?

The patent impacts the pharmaceutical industry by providing more efficient and pure methods for synthesizing hydromorphone and hydrocodone, which are essential for reducing production costs and ensuring drug safety and efficacy.

What is the term of protection for this patent?

The patent provides a 20-year term of protection from the date of filing, subject to the payment of maintenance fees.

Sources

  1. US6589960B2 - Hydromorphone and hydrocodone compositions and methods for their synthesis - Google Patents
  2. Patent FAQs - USPTO
  3. Evidence-Based Policy: Understanding the Technology Landscape - McGill University
  4. US6512117B1 - Hydromorphone and hydrocodone compositions and methods for their synthesis - Google Patents
  5. Patents & Trademarks - Library Guides at Penn State University

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,589,960

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.